Optimal cytoreduction for advanced epithelial ovarian cancer

Optimal cytoreduction for advanced epithelial ovarian cancer

This article is review of literature on role of surgery in the initial management of advanced stage ovarian cancer, focusing on the definition of optimum surgical cytoreduction, assessment of resectability, estimation of the risk of postoperative complications. Analyze of published scien- tific data...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Kormosh, K. P. Laktionov, N. S. Kerzhkovskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2014-08-01
Series:	Опухоли женской репродуктивной системы
Subjects:	ovarian cancer stage iii-iv surgical cytoreduction
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/278
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

REPEATED OPTIMAL CYTOREDUCTIVE SURGERIES IN COMBINED MODALITY TREATMENT OF OVARIAN CANCER. CASE REPORT
by: S. V. Molchanov, et al.
Published: (2017-07-01)

Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
by: Bhatt Aditi, et al.
Published: (2024-07-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

Cytoreductive surgery with multimodal therapies in advanced or metastatic ovarian, colorectal, and gastric cancers: a systematic review and meta-analysis of randomized trials
by: Xiaojun Yuan, et al.
Published: (2025-07-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Analysis of the effectiveness of primary treatment of stage IA–IIA ovarian cancer
by: V. N. Zhurman, et al.
Published: (2024-11-01)

Modern clinical portrait of ovarian cancer patient in the Novosibirsk region
by: A. V. Tarkhov, et al.
Published: (2025-03-01)

Radiologic and surgical peritoneal cancer index in patients with low grade serous ovarian carcinoma
by: Rachel R. Pacyna, et al.
Published: (2025-08-01)

Survival Outcomes in Epithelial Ovarian Cancer: The Role of the Ovarian Cancer-specific Comorbidity Index
by: İrem Küçükşahin, et al.
Published: (2025-08-01)

CYTOREDUCTIVE OPERATIONS IN TREATMENT OF THE PATIENTS OF ELDERLY AND SENILE AGE WITH DISSEMINATED FORMS OF COLORECTAL CANCER
by: N. A. Maistrenko, et al.
Published: (2016-04-01)

Primary versus interval debulking surgery in the management of ovarian cancer patients, current data summary
by: Victoria Psomiadou, et al.
Published: (2022-04-01)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
by: Raymond Hayler, et al.
Published: (2025-07-01)

Astragaloside-IV Inhibits Metastasis by Suppressing the SDF-1/CXCR4 Axis and Activating Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells
by: Burçin İrem Abas, et al.
Published: (2024-05-01)

Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment
by: N. G. Kormosh, et al.
Published: (2014-07-01)

Remote results of treatment of patients with advanced ovarian cancer after interval and delayed cytoreductive surgery: a retrospective single-center study
by: P. I. Sorokin, et al.
Published: (2025-05-01)

The impact of deferred cytoreductive nephrectomy on survival in advanced renal cell carcinoma: A systematic review and meta-analysis
by: Mohammad Taufiq Alamsyah, et al.
Published: (2025-04-01)

Quality of life in patients with advanced ovarian cancer under personalised treatment: the impact of HIPEC
by: V. Maksymovskyi, et al.
Published: (2025-08-01)

A catalog of numerical centrosome defects in epithelial ovarian cancers
by: Jean‐Philippe Morretton, et al.
Published: (2022-09-01)

Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
by: E. A. Ushkalova, et al.
Published: (2016-11-01)

Breast conserving surgery in the treatment of breast cancer stage III
by: D. V. Khaylenko, et al.
Published: (2016-06-01)

Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis– causes and implication on outcomes in a population-based study
by: Mattias Lepsenyi, et al.
Published: (2025-04-01)

Retrospective evaluation of anesthesia management and clinical outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Ahmet Kaya, et al.
Published: (2025-07-01)

Peritoneal Carcinomatosis in Patients with Locally Advanced Colon Cancer: Literature Review
by: S. Yu. Trishchenkov, et al.
Published: (2025-08-01)

Imunotherapy opportunities in ovarian cancer
by: I. Zh. Shubina, et al.
Published: (2014-07-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

Prognostic and Predictive Value of Systemic Inflammatory Markers in Epithelial Ovarian Cancer
by: Cem İdrisoğlu, et al.
Published: (2025-02-01)

Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
by: Zihan Li, et al.
Published: (2025-07-01)

OVARIAN CANCER STAGING: COMPARISON BETWEEN DIFFUSION-WEIGHTED MRI AND MULTISPIRAL COMPUTED TOMOGRAPHY
by: A. E. Solopova, et al.
Published: (2017-06-01)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
by: Huai‐Qiang Ju, et al.
Published: (2019-09-01)

Giant borderline ovarian tumours – review of the literature
by: Sadlecki Pawel, et al.
Published: (2025-08-01)

The gut microbiome and ovarian cysts: a mendelian randomization study
by: Jiahui Qu, et al.
Published: (2025-08-01)

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation
by: Alessandra Dall'Acqua, et al.
Published: (2017-08-01)

CURRENT POSSIBILITIES OF MAGNETIC – RESONANCE IMAGING IN DETECTION OF OVARIAN CANCER
by: N. A. Rubtsova, et al.
Published: (2017-03-01)

Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer
by: Chang Su, et al.
Published: (2025-05-01)

High-Risk Factors and Therapeutic Advances in Ovarian Cancer
by: Xiaoyu SHA, et al.
Published: (2025-07-01)

Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
by: V. A. Markovich, et al.
Published: (2023-02-01)

Early ovarian cancer: our view of the problem
by: K. I. Zhordania, et al.
Published: (2014-08-01)

Is the tail of the pancreas always tumor-infiltrated when macroscopically affected during cytoreductive surgery? A clinicopathological study and experience from a high-volume center
by: Miklos Acs, et al.
Published: (2025-07-01)

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study
by: Petersen Elisabeth Krogsgaard, et al.
Published: (2025-04-01)

Applications of Nanoparticles in the Diagnosis and Treatment of Ovarian Cancer
by: Ahmed El-Mallul, et al.
Published: (2025-08-01)